Page 153 - Mployee Wellness Programs News Today

Artificial Intelligence shows great potential for behavioral healthcare, but it has a ways to go, said Taft Parsons III, vice president and chief psychiatric officer of CVS Health. He made these comments Tuesday at the HIMSS 2023 conference in Chicago.

Acquiring Bellus Health gives GSK a drug for recurrent chronic cough that could offer a better side effect profile compared to a Merck drug that addresses the same target. Bayer was also pursuing the target, but stopped work on its drug candidate last year.

In a recent interview, Dr. Jesse Ehrenfeld, the president-elect at the American Medical Association, outlined how the major pain point of physicians has gone from the EHR to prior authorizations requests. But none of the individual efforts that payers are making is enough.

Epic is welcoming generative AI’s entrance into healthcare. The company is expanding its existing collaboration with Microsoft by integrating OpenAI services, such as GPT-4, into its EHR. The partners have already begun piloting OpenAI services at a few health systems, including UC San Diego Health, UW Health and Stanford Health Care.

Innovaccer launched a new product called Sara, a conversational AI assistant designed to help executives at health systems and payers make better use of their data. It allows executives can ask complex questions about their organization’s patients or members and get immediate answers on clinical, financial or operational metrics.

Merck is acquiring Prometheus Biosciences and a lead drug candidate in development for inflammatory bowel disorders. The deal comes as Merck looks for drug prospects that could make up for revenue declines facing blockbuster seller Keytruda, which faces patent expirations in coming years.

Express Scripts released several new solutions last week that aim to improve drug price transparency, including a cap on out-of-pocket costs for prescription drugs for consumers. The news comes amid increasing scrutiny against pharmacy benefit managers.

Modernizing the financial experience is about more than payment: it requires a comprehensive approach that includes pre-registration activities and extending the streamlined digital experience into the point of care.

ThirtyFiveBio aims to treat gastrointestinal cancer by targeting a so-called orphan receptor called GPR35. The biotech startup is revealing its science at the American Association of Cancer Research annual meeting.

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.